Clincosm LogoSign in Get a demo

Chronic Hepatitis B

Showing 51 - 75 of 400
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis B Trial (PEG IFN a-2b; TAF)

Not yet recruiting
  • Chronic Hepatitis B
  • PEG IFN α-2b; TAF
  • (no location specified)
Aug 5, 2022

Chronic Hepatitis b Trial in Guangzhou (LP-128 capsules, Matching Placebo)

Recruiting
  • Chronic Hepatitis b
  • LP-128 capsules
  • Matching Placebo
  • Guangzhou, Guangdong, China
    NanFang Hospital of Southern Medical University
Aug 2, 2022

Chronic Hepatitis b Trial in Beijing (ASC22, sodium chloride)

Active, not recruiting
  • Chronic Hepatitis b
  • Beijing, China
    Peking University First Hospital
Jul 18, 2022

TAF to Prevent MTCT of HBV in Middle/Late Pregnancies With High

Recruiting
  • Chronic Hepatitis b
  • Pregnancy Related
    • Guangzhou, Guangdong, China
      The Third Affiliated Hospital, Guangzhou Medical University
    Jul 18, 2022

    Chronic Hepatitis B Trial in China (Peginterferon alfa-2b injection, TDF)

    Active, not recruiting
    • Chronic Hepatitis B
    • Peginterferon alfa-2b injection
    • TDF
    • Beijing, China
    • +32 more
    Jul 17, 2022

    Chronic Hepatitis B Trial in Worldwide (TAF, Placebo)

    Recruiting
    • Chronic Hepatitis B
    • Los Angeles, California
    • +58 more
    Jul 14, 2022

    Chronic Hepatitis B Trial in Zhengzhou (continuous treatment, pulse therapy)

    Recruiting
    • Chronic Hepatitis B
    • continuous treatment
    • pulse therapy
    • Zhengzhou, Henan, China
      Henan Provincial People's Hospital
    Jul 13, 2022

    Chronic Hepatitis B Trial in Zhengzhou (PegIFN a- 2b)

    Completed
    • Chronic Hepatitis B
    • PegIFN α- 2b
    • Zhengzhou, Henan, China
      Henan Provincial People's Hospital
    Jul 11, 2022

    Chronic Hepatitis b, Liver Fibrosis Trial in Konya (Serum regucalcin level)

    Completed
    • Chronic Hepatitis b
    • Liver Fibrosis
    • Serum regucalcin level
    • Konya, Turkey
      Konya Training and Research Hospital
    Jun 23, 2022

    Chronic Hepatitis B Trial in Shatin (Tenofovir alafenamide, Entecavir)

    Not yet recruiting
    • Chronic Hepatitis B
    • Shatin, Hong Kong
      Prince of Wales Hospital
    Jun 15, 2022

    Chronic Hepatitis B Trial in Auckland (TAF, TDF, Other approved antivirals)

    Completed
    Has Results
    • Chronic Hepatitis B
    • Auckland, New Zealand
      Auckland City Hospital
    Jun 7, 2022

    Chronic Hepatitis B Trial in Melbourne (162, Placebo)

    Recruiting
    • Chronic Hepatitis B
    • 162
    • Placebo
    • Melbourne, Australia
      Nucleus Network Pty Ltd
    Jun 5, 2022

    Chronic Hepatitis b, NAFLD, Cirrhosis Trial in Hong Kong (Empagliflozin 10 MG, Placebo pills)

    Recruiting
    • Chronic Hepatitis b
    • +5 more
    • Empagliflozin 10 MG
    • Placebo pills
    • Hong Kong, Hong Kong, China, Hong Kong
      The University of Hong Kong/Queen Mary Hospital
    May 31, 2022

    Chronic Hepatitis B Trial in Hannover (Human hepatitis B Immunoglobulin (Hepatect®CP/Zutectra®))

    Recruiting
    • Chronic Hepatitis B
    • Human hepatitis B Immunoglobulin (Hepatect®CP/Zutectra®)
    • Hannover, Lower Saxony, Germany
      Hannover Medical School, Department for Gastroenterology, Hepato
    May 31, 2022

    Chronic Hepatitis b Trial in Chisinau, Kyiv (ATI-2173 25mg, Vebicorvir 300mg, Viread 300Mg Tablet)

    Terminated
    • Chronic Hepatitis b
    • ATI-2173 25mg
    • +2 more
    • Chisinau, Republic Of Moldova, Moldova, Republic of
    • +1 more
    May 25, 2022

    Chronic Hepatitis B Trial in Changchun (GLS4, RTV, TAF)

    Completed
    • Chronic Hepatitis B
    • Changchun, Jilin, China
      The First Hospital of Jilin University
    May 20, 2022

    Chronic Hepatitis B Trial in Beijing (PEG-IFN)

    Recruiting
    • Chronic Hepatitis B
    • Beijing, Beijing, China
      Department of Hepatology Division 2, Beijing Ditan Hospital
    May 9, 2022

    Chronic Hepatitis B Trial in Beijing (PEG-IFN)

    Recruiting
    • Chronic Hepatitis B
    • Beijing, Beijing, China
      Department of Hepatology Division 2, Beijing Ditan Hospital
    May 9, 2022

    Chronic Hepatitis B, Hepatic Fibrosis, Fatty Liver Trial in Seoul

    Active, not recruiting
    • Chronic Hepatitis B
    • +2 more
      • Seoul, Korea, Republic of
        Seoul Metropolitan Government Seoul National University
      May 3, 2022

      Chronic Hepatitis b Trial in Hong Kong (RBD1016, Placebo, Entecavir)

      Recruiting
      • Chronic Hepatitis b
      • Hong Kong, China
        The University of Hong Kong
      Apr 24, 2022

      Chronic Hepatitis B Trial in Taiwan, Thailand (ChAdOx1-HBV, MVA-HBV, Nivolumab)

      Not yet recruiting
      • Chronic Hepatitis B
      • ChAdOx1-HBV
      • +2 more
      • Chiayi City, Taiwan
      • +9 more
      Apr 22, 2022

      Steatohepatitis in Chronic Hepatitis B

      Completed
      • Fatty Liver
      • Chronic Hepatitis b
      • Antiviral Agents
      • Bangkoknoi, Bangkok, Thailand
        Faculty of Medicine Siriraj Hospital
      Mar 30, 2022

      Chronic Hepatitis B Trial run by the NIDDK (hepatitis B immune globulin (HBIg), Pegylated interferon alfa (pegIFN))

      Withdrawn
      • Chronic Hepatitis B
      • hepatitis B immune globulin (HBIg)
      • Pegylated interferon alfa (pegIFN)
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Apr 4, 2022

      Chronic Hepatitis B Trial in Hong Kong, Korea, Republic of (Inarigivir Soproxil, TAF)

      Terminated
      Has Results
      • Chronic Hepatitis B
      • Inarigivir Soproxil
      • TAF
      • Hong Kong, Hong Kong
      • +12 more
      Mar 8, 2022

      Novel Simplified Score for Chronic Hepatitis B Treatment

      Not yet recruiting
      • Chronic Hepatitis B
      • TREAT-B score
      • Bangkok, Thailand
        Siriraj Hospital
      Apr 1, 2022